Literature DB >> 17010384

Boolean network analysis of a neurotransmitter signaling pathway.

Simone Gupta1, Siddharth S Bisht, Ritushree Kukreti, Sanjeev Jain, Samir K Brahmachari.   

Abstract

BACKGROUND: A Boolean network is a simple computational model that may provide insight into the overall behavior of genetic networks and is represented by variables with two possible states (on/off), of the individual nodes/genes of the network. In this study, a Boolean network model has been used to simulate a molecular pathway between two neurotransmitter receptor, dopamine and glutamate receptor, systems in order to understand the consequence of using logic gate rules between nodes, which have two possible states (active and inactive).
RESULTS: The dynamical properties of this Boolean network model of the biochemical pathway shows that, the pathway is stable and that, deletion/knockout of certain biologically important nodes cause significant perturbation to this network. The analysis clearly shows that in addition to the expected components dopamine and dopamine receptor 2 (DRD2), Ca(2+) ions play a critical role in maintaining stability of the pathway.
CONCLUSION: So this method may be useful for the identification of potential genetic targets, whose loss of function in biochemical pathways may be responsible for disease onset. The molecular pathway considered in this study has been implicated with a complex disorder like schizophrenia, which has a complex multifactorial etiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010384     DOI: 10.1016/j.jtbi.2006.08.014

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  21 in total

1.  Polynomial-time algorithm for controllability test of a class of boolean biological networks.

Authors:  Koichi Kobayashi; Jun-Ichi Imura; Kunihiko Hiraishi
Journal:  EURASIP J Bioinform Syst Biol       Date:  2010-08-25

2.  Role of cholinergic system and calcium synchronization in schizophrenia.

Authors:  Atmaram Yarlagadda; Anita H Clayton
Journal:  Psychiatry (Edgmont)       Date:  2009-04

3.  The blood brain barrier and the role of ratiometric molecular analysis in schizophrenia.

Authors:  Atmaram Yarlagadda; Christiane S Hampe; Anita H Clayton
Journal:  Psychiatry (Edgmont)       Date:  2010-12

4.  Blood brain barrier: the role of calcium homeostasis.

Authors:  Atmaram Yarlagadda; Shaifali Kaushik; Anita H Clayton
Journal:  Psychiatry (Edgmont)       Date:  2007-12

5.  A unifying modelling formalism for the integration of stoichiometric and kinetic models.

Authors:  Jorge Júlvez; Stephen G Oliver
Journal:  J R Soc Interface       Date:  2020-08-05       Impact factor: 4.118

6.  Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic data.

Authors:  Alexander Mitsos; Ioannis N Melas; Paraskeuas Siminelakis; Aikaterini D Chairakaki; Julio Saez-Rodriguez; Leonidas G Alexopoulos
Journal:  PLoS Comput Biol       Date:  2009-12-04       Impact factor: 4.475

Review 7.  Logic-based models for the analysis of cell signaling networks.

Authors:  Melody K Morris; Julio Saez-Rodriguez; Peter K Sorger; Douglas A Lauffenburger
Journal:  Biochemistry       Date:  2010-04-20       Impact factor: 3.162

8.  Boolean AND and OR logic for cell signalling gateways: a communication perspective.

Authors:  Manav R Bhatnagar
Journal:  IET Nanobiotechnol       Date:  2018-12       Impact factor: 1.847

9.  Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction.

Authors:  Julio Saez-Rodriguez; Leonidas G Alexopoulos; Jonathan Epperlein; Regina Samaga; Douglas A Lauffenburger; Steffen Klamt; Peter K Sorger
Journal:  Mol Syst Biol       Date:  2009-12-01       Impact factor: 11.429

10.  NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks.

Authors:  Suhas V Vasaikar; Aditya K Padhi; Bhyravabhotla Jayaram; James Gomes
Journal:  BMC Neurosci       Date:  2013-01-03       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.